Dr Luigi Ombrato

Luigi Ombrato

Group Leader / Lecturer

Barts Cancer Institute - QMUL
ORCID Google Scholar LinkedIn X

Research

Tumour Microenvironment, Metastasis, Immune cells, Stromal cells, Immunotherapy

Cancer Models

Interests

Our lab uses 3D models (including heterotypic spheroids/tumoroids, transwell scaffolds, hydrogels) to study the interactions between cancer cells, stromal cells and immune cells. These systems help us to dissect the molecular mechanims underlying metastasis formation and to understand how the different cellular components within the tumour microenvironment communicate with each others and with the cancer cells during the establishment of a tumour supportive niche. Cancers of interest: breast, colorectal, pancreatic.

Publications

solid heart iconPublications of specific relevance to Predictive in vitro Models

2024

Ermogenous C, Ombrato L and Beattie G (2024). Abstract B022: Investigating how monocytes impair NK cell cytotoxicity in lung metastasis of triple-negative breast cancer. American Association for Cancer Research (AACR)  Cancer Research  vol. 84, (22_Supplement) b022-b022.  
Perdrix Rosell A, Maiques O, Martin JAJ, Chakravarty P, Ombrato L, Sanz-Moreno V and Malanchi I (2024). Corrigendum to “Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth” [Cancer Lett. 544 (2022), 215800]. Elsevier  Cancer Letters  vol. 597,  
Rodrigues FS, Karoutas A, Ruhland S, Rabas N, Rizou T, Di Blasio S, Ferreira RMM, Bridgeman VL, Goldstone R, Sopena ML, Lee J-H, Ombrato L and Malanchi I (2024). Bidirectional activation of stem-like programs between metastatic cancer and alveolar type 2 cells within the niche. Elsevier  Developmental Cell  vol. 59, (18) 2398-2413.e8.  

2023

Kafka A, Ermogenous C and Ombrato L (2023). Isolation of Live Immune Cells from the Tumor Microenvironment by FACS. Springer Nature  Methods in Molecular Biology  vol. 2748, 1-12.  

2022

Ombrato L (2022). In vivo labelling system to study cell neighbourhoods. Springer Nature  Nature Reviews Cancer  vol. 22, (12) 661-661.  
Perdrix Rosell A, Maiques O, Martin JAJ, Chakravarty P, Ombrato L, Sanz-Moreno V and Malanchi I (2022). Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth. Elsevier  Cancer Letters  vol. 544,  
Borel V, Boeing S, Van Wietmarschen N, Sridharan S, Hill BR, Ombrato L, Perez-Lloret J, Jackson D, Goldstone R, Boulton SJ, Nussenzweig A and Bellelli R (2022). Disrupted control of origin activation compromises genome integrity upon destabilization of Polε and dysfunction of the TRP53-CDKN1A/P21 axis. Elsevier  Cell Reports  vol. 39, (9)  
Nolan E, Bridgeman VL, Ombrato L, Karoutas A, Rabas N, Sewnath CAN, Vasquez M, Rodrigues FS, Horswell S, Faull P, Carter R and Malanchi I (2022). Author Correction: Radiation exposure elicits a neutrophil-driven response in healthy lung tissue that enhances metastatic colonization. Springer Nature  Nature Cancer  vol. 3, (4) 519-519.  
Nolan E, Bridgeman VL, Ombrato L, Karoutas A, Rabas N, Sewnath CAN, Vasquez M, Rodrigues FS, Horswell S, Faull P, Carter R and Malanchi I (2022). Radiation exposure elicits a neutrophil-driven response in healthy lung tissue that enhances metastatic colonization. Springer Nature  Nature Cancer  vol. 3, (2) 173-187.  

2021

Rosell AP, Maiques O, Chakravarty P, Ombrato L, Sanz-Moreno V and Malanchi I (2021). Early functional mismatch between breast cancer cells and their tumour microenvironment suppresses long term growth. Cold Spring Harbor Laboratory   
Passaro D, Garcia-Albornoz M, Diana G, Chakravarty P, Ariza-McNaughton L, Batsivari A, Borràs-Eroles C, Abarrategi A, Waclawiczek A, Ombrato L, Malanchi I, Gribben J and Bonnet D (2021). Integrated OMICs unveil the bone-marrow microenvironment in human leukemia. Elsevier  Cell Reports  vol. 35, (6)  

2020

Ombrato L, Nolan E, Passaro D, Kurelac I, Bridgeman VL, Waclawiczek A, Duarte D, Lo Celso C, Bonnet D and Malanchi I (2020). Generation of neighbor-labeling cells to study intercellular interactions in vivo. Springer Nature  Nature Protocols  vol. 16, (2) 872-892.  
Ombrato L and Montagner M (2020). Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells. Frontiers Media  Frontiers in Oncology  vol. 10, 594514-594514.  

2019

Ombrato L, Nolan E, Kurelac I, Mavousian A, Bridgeman VL, Heinze I, Chakravarty P, Horswell S, Gonzalez-Gualda E, Matacchione G, Weston A, Kirkpatrick J, Husain E, Speirs V, Collinson L, Ori A, Lee J-H and Malanchi I (2019). Author Correction: Metastatic-niche labelling reveals parenchymal cells with stem features. Springer Nature  Nature  vol. 575, (7784) e8-e8.  
Ombrato L, Nolan E, Kurelac I, Mavousian A, Bridgeman VL, Heinze I, Chakravarty P, Horswell S, Gonzalez-Gualda E, Matacchione G, Weston A, Kirkpatrick J, Husain E, Speirs V, Collinson L, Ori A, Lee J-H and Malanchi I (2019). Metastatic-niche labelling reveals parenchymal cells with stem features. Springer Nature  Nature  vol. 572, (7771) 603-608.  
Ombrato L and Malanchi I (2019). Subclonal cooperation rewrites metastasis. Springer Nature  Nature Cell Biology  vol. 21, (7) 797-798.  
Kurelac I, Iommarini L, Vatrinet R, Amato LB, De Luise M, Leone G, Girolimetti G, Umesh Ganesh N, Bridgeman VL, Ombrato L, Columbaro M, Ragazzi M, Gibellini L, Sollazzo M, Feichtinger RG, Vidali S, Baldassarre M, Foriel S, Vidone M, Cossarizza A, Grifoni D, Kofler B, Malanchi I, Porcelli AM and Gasparre G (2019). Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses. Springer Nature  Nature Communications  vol. 10, (1)  

2015

del Pozo Martin Y, Park D, Ramachandran A, Ombrato L, Calvo F, Chakravarty P, Spencer-Dene B, Derzsi S, Hill CS, Sahai E and Malanchi I (2015). Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization. Elsevier  Cell Reports  vol. 13, (11) 2456-2469.  

2014

Aulicino F, Theka I, Ombrato L, Lluis F and Cosma MP (2014). Temporal Perturbation of the Wnt Signaling Pathway in the Control of Cell Reprogramming Is Modulated by TCF1. Elsevier  Stem Cell Reports  vol. 2, (5) 707-720.  
Ombrato L and Malanchi I (2014). The EMT Universe: Space between Cancer Cell Dissemination and Metastasis Initiation. Begell House  Critical Reviews™ in Oncogenesis  vol. 19, (5) 349-361.  

2012

Ombrato L, Lluis F and Cosma MP (2012). Regulation of self-renewal and reprogramming by TCF factors. Taylor & Francis  Cell Cycle  vol. 11, (1) 39-47.  

2011

Lluis F, Ombrato L, Pedone E, Pepe S, Merrill BJ and Cosma MP (2011). T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proceedings of the National Academy of Sciences  Proceedings of the National Academy of Sciences of the United States of America  vol. 108, (29) 11912-11917.  

2007

Buccigrossi V, de Marco G, Bruzzese E, Ombrato L, Bracale I, Polito G and Guarino A (2007). Lactoferrin Induces Concentration-Dependent Functional Modulation of Intestinal Proliferation and Differentiation. Springer Nature  Pediatric Research  vol. 61, (4) 410-414.  

Grants

solid heart iconGrants of specific relevance to Predictive in vitro Models
bullet iconControlling metastasis formation through inhibition of myeloid cell-myeloid cell cross-talk
Luigi Ombrato
£744,164 CR-UK Cancer Research UK (01-10-2024 - 30-09-2030)
bullet iconUnderstanding the systemic effects of adjuvant radiotherapy on metastasis
Luigi Ombrato
£74,695 Barts and the London Charity (08-04-2024 - 07-04-2025)
bullet iconKTP with LiftBioSciences: 3D TME model to study neutrophil cytotoxicity (PI: Luigi Ombrato)
Luigi Ombrato and Oliver Pearce
£232,790 Innovate UK (30-08-2023 - 29-08-2025)
bullet iconCharacterising neutrophil:macrophage cross-talk in metastatic niches
Luigi Ombrato
£99,997 AMS Academy of Medical Sciences (01-03-2022 - 31-07-2025)


bullet iconCharacterise the immuno-metabolic reprogramming in colorectal cancer liver metastasis
Luigi Ombrato
£50,000 Bowel Research UK ( formerly Bowel & Cancer Research) (01-09-2021 - 09-01-2024)